Penn Capital Management Company, LLC

Position in LNTH — Lantheus Holdings, Inc.

CIK 1158202 PHILADELPHIA, PA

Back to LNTH Full portfolio

Position in LNTH

as of Jun 30, 2026 · filed Jul 30, 2026 Compact

Position Value

$17,071,114

+$2,733,382 QoQ

Shares Held

153,877

+4.7% QoQ

Ownership

0.236%

of shares outstanding

% of Portfolio

1.09%

of 13F equity value

Holder Rank

#65

of 466 holders

Holding Since

Mar 2022

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in LNTH Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Penn Capital Management Company, LLC holds $80,501,316 across 6 Drug Manufacturers - Specialty & Generic names. LNTH ranks #4 (21.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	KNSA	Kiniksa Pharmaceuticals International, plc	368,114	$23,540,890
2	AMRX	Amneal Pharmaceuticals, Inc.	1,181,176	$20,446,156
3	ANIP	Ani Pharmaceuticals Inc	207,362	$17,165,426
4	LNTH	Lantheus Holdings, Inc. This page	153,877	$17,071,114
5	NBIX	Neurocrine Biosciences Inc	10,600	$1,786,524
6	XERS	Xeris Biopharma Holdings, Inc.	62,021	$491,206

All Filings in LNTH

Export CSV

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$17,071,114	153,877	+4.7%	Shares	Sole	2026-07-30
2025-03-31	$14,337,732	146,903	+11.5%	Shares	Sole	2025-05-14
2024-12-31	$11,790,291	131,794	-11.0%	Shares	Sole	2025-02-14
2023-06-30	$12,425,363	148,062	-20.5%	Shares	Sole	2023-08-14
2023-03-31	$15,384,230	186,340	-17.9%	Shares	Sole	2023-05-16
2022-12-31	$11,569,856	227,038	+25.1%	Shares	Sole	2023-02-14
2022-09-30	$12,764,543	181,495	-7.8%	Shares	Sole	2022-12-09
2022-06-30	$13,001,042	196,896	-13.6%	Shares	Sole	2022-08-15
2022-03-31	$12,609,850	227,985	—	Shares	Sole	2022-05-17
No filing history on record for this holder in this stock.